Ttnp news

The clone army is always ahead: counterfeit Galaxy Note 9 units already out in the wild
Jan 17, 2020 · Titan Pharmaceuticals, Inc. As a result, the company has an EPS growth of -7. (TTNP) stock price, news, historical charts, analyst ratings and financial information from WSJ. (TTNP) SEC Filings - Get realtime SEC filings forTitan Pharmaceuticals, Inc. (TTNP) Titan Pharmaceuticals, Inc. 303. Market Cap 36. 52M with the total Outstanding Shares of 96. 9 million from the exercise of roughly 26. Titan Pharmaceuticals Reports First Quarter 2020 Financial Results · View All Press Releases. com SOUTH SAN FRANCISCO, Calif. stock information, including NASDAQ:TTNP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTNP stock news, and many more online research tools to help you make informed decisions. Penny Stocks (PennyStocks. 27 until finishing in the latest session at $0. 70% from a day low at $0. (NASDAQ:TTNP) went down by -3. Titan Pharmaceuticals (TTNP) News Headlines. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. (TTNP) on Friday reported a loss of $5. 30%. Over the last year, it has lost the Braeburn partnership, Get Titan Pharmaceuticals Inc (TTNP:NASDAQ) real-time stock quotes, news and financial information from CNBC. 44%. 95% to its 50 Day low spot and changed -36. Home · News · Overview. Next Gen consoles - ( TTNP EP Zero) - Duration: 31 minutes. Stock analysis for Titan Pharmaceuticals Inc (TTNP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. com May 11, 2020 · On Friday, May 08, 2020, the Company, Titan Pharmaceuticals, Inc. 85. InvestorsObserver’s proprietary ranking system, gives TTNP stock a score of 64 out of a p Titan Pharmaceuticals Inc (TTNP) NASDAQ Symbol Exchange TTNP News This page features the latest news about the Titan Pharma stock. 3012-0. By John Vandermosten, CFA NASDAQ:TTNP READ THE FULL TTNP RESEARCH REPORT Titan Pharmaceuticals, Inc. 31, which belongs to Healthcare sector and Biotechnology industry. com Titan Pharma stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Source: Date Headline; TTNP: First Quarter 2020 Financial and Operational Results finance. Titan Pharmaceuticals (NASDAQ:TTNP) last posted its quarterly earnings data on Monday, March 30th. News has analyzed over 4,500 stocks to help investors reach their financial goals. All Rights Reserved. 2385/share level. Profitability Ratios (ROE, ROA, ROI): Looking into the profitability ratios of TTNP stock, an investor will find its ROE, ROA, ROI standing at 0%, -199. 33 0. Find market predictions, TTNP financials and market news. TTNP updated stock price target summary. First Quarter 2020 HighlightsIn January 2020, Titan completed an offering resulting in net cash proceeds Check out our TTNP stock analysis, current TTNP quote, charts, and historical prices for Titan Pharma stock Find the latest Titan Pharmaceuticals, Inc. Current stock quote for Titan Pharmaceuticals Inc. 299 and dropped to a low of $0. Currently at 0. On PennyStocks. 2% and -307. 6 million in its first quarter. com you will find a comprehensive list of Penny Stocks & discover the best Penny Stocks to buy, top penny stock news and micro-cap stock articles. We just know when to sell and most of us are militant about our downside rules. 9 Million From Exercise Of Warrants Find the latest Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is rocketing in the market this morning, trading on gains of around 20% early on. (TTNP) would settle between $0. 33 During the day the stock fluctuated 12. 2 million, vs. 26. 15 May 2020 Titan Pharmaceuticals Reports First Quarter 2020 Financial Results. (TTNP) shares reached a high of $0. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Titan Pharmaceuticals  Titan Pharmaceuticals stock quote and TTNP charts. Dive deeper with interactive charts and top stories of TITAN PHARMACEUTICALS, INC. 04%, while its annual performance rate touched -82. 17 in a total of its share price and finished its trading at 0. 0. 32 to a day high of $0. 03 is the 14-day ATR for Titan Pharmaceuticals Inc. 96 and move down -684%, while TTNP stocks collected +6. The stock’s Relative Strength Index (RSI) is 50. com: The #1 Source For Dividend Investing. 52%. TTNP shows that the shares of the company are now Sold by investors. 285 0. , TTNP stock construct a change of -4. Common Stock (TTNP) at Nasdaq. 4% *Last Qtr. 0016 or -0. As a result of the news, we now know that a large population of patients has gained access to the PROBUPHINE implant. We buy based on the same news as you. 86% higher on its value in year-to-date trading and has touched a low of $0. Jan 22, 2020 · Titan Pharmaceuticals Inc is a specialty pharmaceutical company. Technical Analysis of Mind-blowing stock TTNP: The stock price moved with change of 38. 08% on 05/22/20. (TTNP) - view income statements, balance sheet, cash flow, and key financial ratios for Titan Pharmaceuticals, Inc. 07), versus ($0. one of them known as PROBUPHINE […] Titan Pharmaceuticals Receives $5. Traders and investors may also choose to study the ATR or Average True Range when concentrating on technical inventory assessment. (NASDAQ:TTNP) has a beta of 0. Mar 18, 2020 · Titan Pharmaceuticals, Inc. com Titan Pharmaceuticals news and TTNP price. Titan Pharmaceuticals News. May 21, 2020 · The BidaskScore of Titan Pharmaceuticals Inc. Common Stock. 08 million shares, Titan Pharmaceuticals (TTNP) recorded a trading volume of 4. XSPA 5. 47. 32 to $0. 35% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. 34) reported last year. TTNP is UP 27% ABOVE 200 day SMA SOUTH SAN FRANCISCO, Calif. Titan Pharmaceuticals, Inc. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. and all the companies you research at NASDAQ. (NASDAQ: TTNP) reported a loss of $0. (NASDAQ:TTNP) is 0. 3M. 78% or $0. The stocks have a year to date performance of 7. Follow TTNP. TTNP; News-TTNP. 004 (1. (TTNP). The company also improved its distribution process, taking what had been up to three months to deliver a Titan Pharmaceuticals, TTNP: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short Penny Stocks (PennyStocks. 1)* Titan Pharmaceuticals, Inc. Jan 16, 2020 · On January 13, 2020, Titan Pharmaceuticals, Inc. The specialty pharmaceutical company reported ($0. 01 higher in the latest Read more News TTNP on StockCharts. Earnings; Guidance; Dividends; M&A; Buybacks; WANT TO CATCH TTNP NEWS BEFORE IT CHANGES THE STOCK PRICE? Titan Pharmaceuticals (NASDAQ:TTNP) Stock Quotes and News . 38, 52 Wk Low 0. XpresSpa GroupStock. (TTNP) stock news and headlines to help you in your trading and investing decisions. 26 with a heavy trading volume of 4693328 shares. [NASDAQ: TTNP] closed the trading session at $0. TTNP Market Performance TTNP stocks went up by 9. Network News Transfer Protocol(ネットワーク ニュース トランスファー プロトコル、 NNTP)は、インターネットアプリケーションプロトコルのひとつである。おもに、ネット ニュース (Usenet) の記事を読むことと記事を投稿することのために使われる。記事は ニュース  The latest Tweets from TNN NEWS (@Trainfo_NEWS). 1991, while the highest price level was $0. Get the latest Titan Pharmaceuticals Inc TTNP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. (NASDAQ: TTNP) today announced it has entered into a securities purchase agreement with a single accredited Apr 22, 2020 · A Look At Titan Pharmaceuticals (NASDAQ:TTNP) With the previous 100-day trading volume average of 13. Now it’s just a bunch of GNUS bagholders and pumpers trying to pump their stocks that are already %200 up, its getting really old really fast, settle down fellas. It is engaged in the development and commercialization of pharmaceutical products. 33 percent (↓ / Loss) in a total of its share price and having its trading value $0. Open 0. 71, measuring its EPS growth this year at 7. 10 ETFs With Most Upside To Analyst Targets Titan Pharmaceuticals financial news headlines. You simply have to look deeper than the share price and explore the fundamentals and future growth potential. Shares are up 1. 08). 96. 78. Events. TradingView UK. You don't TTNP: First Quarter 2020 Financial and Operational Results. TTNP Description — Titan Pharmaceuticals Inc (DE) Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. Free forex prices, toplists, indices and lots more. The gains come after the company announced a Federal supply agreement. 47 percent. (TTNP) stock quote, history, news and other vital information to help you with your stock trading and investing. 15 May 2020 Get instant alerts when news breaks on your stocks. 001 par value (Title of Class of Securities) 888314507 (CUSIP Apr 24, 2020 · A Look At Titan Pharmaceuticals (NASDAQ:TTNP) With the previous 100-day trading volume average of 13. 08) […] Investors are paying close attention to Titan Pharmaceuticals, Inc. 25 in the current trading session, with the day’s gains setting it 0. It opened the trading session at $0. The Company is engaged in developing therapeutics for the treatment of medical disorders. S. The company’s Market capitalization was $29. SOUTH SAN FRANCISCO, Calif. Date Time Source Titan Pharmaceuticals, Inc. (TTNP) ("Titan" or the "Company") today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided an update on its business. Stock Markets close in 6 hours, 13 minutes. […] Mar 30, 2020 · SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. TTNP stock is as of now appearing down return of -23. 00 (0. Titan Pharma (NASDAQ: TTNP) reported Q1 EPS of ($0. Titan Pharmaceuticals (NASDAQ TTNP) News Headlines. 9 Million From Exercise Of Warrants 9:41AM ET 3/05/2020 MT Newswires. Titan Pharmaceuticals Inc. 7M. Upcoming. (NASDAQ: TTNP) ("Titan" or the "Company") today reported financial results for the fourth quarter and full Titan Pharmaceuticals (OTCBB: TTNP) is a biomedical pharmaceutical company most known for its flagship drug, Probuphine, used to treat opioid addiction. Join the Action Alerts PLUS Community today! SUBSCRIBE NOW  22 May 2020 [NASDAQ: TTNP] loss -2. 33 (based on 1 day standard deviation move). 36 . 28. 27 (31. 3% and -307. (NASDAQ:TTNP) issued its quarterly earnings data on Monday, March, 30th. 08 million shares, Titan Pharmaceuticals (TTNP) recorded a trading volume of 3. 20% of gains with the last five trading sessions. 01 points higher today and the only thing that matters is where they go from here. A biopharmaceutical company developing proprietary therapeutics for the treatment of central nervous   15 May 2020 As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. CAPS Rating: No stars. We apologize for any inconvenience. View the latest Titan Pharmaceuticals Inc. May 15, 2020. Passive Investment. 3 million. 14 and a high of $1. TITAN PHARMA INC (TTNP) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. 3575 (+2. Find the latest press releases from Titan Pharmaceuticals, Inc. 47% from a day low at $0. 905 USD. 50%. TTNP : 0. Ever since gapping down on October 16, the daily action is noticeably greater than before. 19M with average trading volume of 11. 14. ( TTNP ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion TTNP is trading DOWN -$-0. Get the latest Titan Pharmaceuticals, Inc. 20 May 2020 $EMAN $TTNP $CHEK check out $CLSK gonna be a runner tomorrow. * q1 revenue $1. Income Statement for Titan Pharmaceuticals, Inc. The TTNP stock was last observed hovering at around $0. TTNP Stock Price The median TTNP price target (a different metric than the average or mean) was $ as of , the highest TTNP price target in the range was $ while the lowest TTNP price target in the range was $, with a standard deviation of $. yahoo. Probuphine has proved to be effective in two clinical studies and one safety study. 89% PDF Titan Pharmaceuticals gained 4. […] May 11, 2020 · On Friday, May 08, 2020, the Company, Titan Pharmaceuticals, Inc. Mar 27, 2020 · Titan Pharmaceuticals, Inc. common stock (TTNP) stock is down -82. 905 USD for 2021 June 08, Tuesday; and 13. May 15, 2020 · SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. $920,000 expected. 03. The EPS of TTNP is strolling at -0. 7%, respectively. Get today's Titan Pharma stock news. . The Fly team scours all sources of company news, from mainstream to cutting edge,then filters out the noise to deliver shortform stories consisting of only market moving content. 98 in a total of its share price and finished its trading at 0. 14 and a $1. Its shares traded higher over the last trading session, gaining 8. Beta 1. (Titan) is a specialty pharmaceutical company. But is this a good or bad sign for the penny stock? Titan Pharma (TTNP) reports earnings on 8/14/2020. The company announced a partnership, exciting investors and sending the stock on a run for… Titan Pharmaceuticals News - TTNP . (US:TTNP) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. 2 million in the period. 38 -9. 2020 is expected to be a huge year for penny stocks. View the latest TTNP stock quote and chart on MSN Money. com - June 1 at 10 Jun 10, 2020 · Titan Pharmaceuticals Inc. 7, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. EPS Growth Rate +79. , May 15, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. 9 percent. 1, it has received proceeds of about $5. Write your thoughts about Titan Pharmaceuticals Inc . Oct 30, 2018 · Titan Pharmaceuticals has been a battleground stock for quite a while. … Titan Pharmaceuticals Stock Price Forecast, TTNP stock price prediction. 5% from yesterday's close of $0. 0%) Upgrade to Real-Time Afterhours (Closed) Current Report Filing (8-k) December 10 2019 - 02:31PM Edgar (US Regulatory) Mar 30, 2020 · — Titan Pharmaceuticals, Inc. Analyzing Titan Pharmaceuticals (NASDAQ:TTNP) stock? View TTNP's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Changes in price are generally the best indicator of sentiment for a  Stock analysis for Titan Pharmaceuticals Inc (TTNP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 08 per share in the fourth quarter of 2019, in line with Wall Street expectation. 1 day ago; 42 views; May 26, 2020 · Titan Pharmaceuticals Inc. By John Vandermosten, CFA NASDAQ:TTNP READ THE FULL TTNP RESEARCH REPORT During 2019 and to date, Titan Pharmaceuticals, Inc. 21. Should I buy or sell TTNP stock? If you are thinking about buying TTNP, make sure you check out the free TTNP stock predictions report provided by MarketClub. (NASDAQ:TTNP) ("Titan" or the "Company") today reported financial results for the first quarter ended March 31, 2020 SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. key stats. 29%). The average equity rating for TTNP stock is currently 2. (TTNP) stock discussion in Yahoo Finance's forum. 018 USD for 2025 June 08, Sunday with technical analysis. 2766 0. com) is the top online destination for all things Micro-Cap Stocks. View live TITAN PHARMACEUTICAL INC chart to track its stock's price action. stock news by MarketWatch. Don't miss TTNP stock next rating changes Titan Pharmaceuticals Reports First Quarter 2020 Financial Results PR Newswire (US) - 5/15/2020 8:45:00 AM: Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020 PR Newswire (US) - 5/11/2020 4:03:00 PM TTNP - Titan Pharmaceuticals Inc. (TTNP) company-issued press releases. 1%: Revenue Growth Rate-100. Catalyst. The San Francisco-based company said it had a loss of 8 cents per share. 24, in the end touching the price of $0. View real-time stock prices and stock quotes for a full financial overview. Day Low 0. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. com. Titan Pharmaceuticals, TTNP: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short TTNP's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend. , Aug. Trade with Jim Cramer 14 Days Free. May 19, 2020 · On 18-05-2020 (Monday), TTNP stock construct a change of -0. About 17 million shares traded hands on 14,915 trades for the day, About Titan Pharmaceuticals, Inc. Recent. — Q4 revenue was flat at $1. The company product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. 1 Year % Chg -72. Titan Pharmaceuticals (TTNP) reported that since Jan. 11. 23 after dropping by -1. 48% all through a week ago and saw bearish return of 11. The increased access and public funding for the treatment means that TTNP can expect to see a dramatic increase in sales ahead. , Stock Symbol: TTNP, Industry: Biotechs, Total Posts: 16149, Last Post: 6/11/2020 1:47:00 PM © 2020 Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) has expanded its distribution network to cover the entire United States working in partnership with several well-known specialty pharmaceutical players. 14%) Titan Pharmaceuticals Reports First Quarter 2020 Financial Results PR Newswire - PRF - Fri May 15, 7:45AM CDT TTNP Stock Forecast and Technical Analysis Buy or Hold candidate since 2020-06-04 Loss -7. Over the last 12 months, TTNP stock dropped by -71. gov - 1 - SECURITIES AND EXCHANGE COMMISSION Washington, D. annual stock financials by MarketWatch. 1%: Normal Earnings Time View today's stock price, news and analysis for Titan Pharmaceuticals Inc. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how TTNP will perform in the near Titan Pharmaceuticals News: This is the News-site for the company Titan Pharmaceuticals on Markets Insider News Live Fashion Learning Spotlight 360° Video Browse channels Sign in to like videos, comment, and subscribe. Message Board Total Posts: 41 Financial summary and company information for Titan Pharmaceuticals, Inc. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation 9:46:35 AM EDT - Wednesday, June 3, 2020 U. 28% in the last trading day (Friday, 12th Jun 2020), rising from $0. 2047 for its downside target. TTNP: Titan Pharmaceuticals Inc - Earnings Announcements. Below are the latest news stories about Titan Pharmaceuticals Inc that investors may wish to consider to help them evaluate TTNP as an investment opportunity. 21 on 03/19/20. Titan Pharmaceuticals (TTNP) stock price prediction is 1. TTNP, Titan Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Titan Pharmaceuticals Stock Quote: TTNP Stock News, Quotes, Analysis | Investors. Refresh or try again later. In depth view into TTNP (Titan Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. (NASDAQ: TTNP) ("Titan" or the "Company") today reported financial results for the first quarter ended March 31, 2020 and provided an update on its business. (NASDAQ: TTNP) is having a great day in the market today, and for good reason. Stocks; Titan Pharmaceuticals Inc Edited Transcript of TTNP earnings conference call or presentation 30 TTNP / Titan Pharmaceuticals, Inc. 258, the range by which the  Latest Stock Picks; News Titan Pharmaceuticals Inc Del (NASDAQ:TTNP). Find the latest Titan Pharmaceuticals, Inc. 's stock rating is based on fundamental analysis. From an enhanced free experience to professional stock picking - we have a great plan for you Find the latest news headlines from Titan Pharmaceuticals, Inc. 42%) Upgrade to Real-Time Premarket . As mentioned above, Titan Pharmaceuticals is having an incredibly strong start to the trading session this morning after news broke from the Trump Administration. : Average % Move 1-Wk after EPS-4. 27. The Titan Pharmaceuticals stock forecast is 1. 23 after jumping by 0. Jun 09, 2020 · Titan Pharmaceuticals, Inc. There are a large number of factors that could be leading to the movement in the stock. 20%. Claim your 1-week free trial to StreetInsider Premium here. TTNP Stock Analysis Overview . Persons that are interested in registering for the company’s earnings conference call can do so using this link. 42 percent and weekly performance of 3. News. 2688, the shares rose to $0. Summary. (TTNP) on Monday reported a loss of $3. 2 million Stock analysis for Lotte Chemical Titan Holding Bhd (TTNP:Bursa Malays) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 0299 below high of day. (NASDAQ:TTNP) announced that it has signed an agreement for Probuphine (buprenorphine) implant to be included on the Federal Supply Schedule (“FSS”), providing U. Media Resources. Stay safe. If that happens, the stock price might even plunge as low as $0. Press Releases, Events and Resources. Titan Pharmaceuticals To Report First Quarter  Latest TTNP News From Around the Web. / Empery Asset Management, LP - TITAN PHARMACEUTICALS, INC. YTD % Chg 95. 01 (2. 3316. 45 1. 84% contrasting with its 50 Day high point. Free real-time prices, trades, and chat. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! TTNP Stock Runs Up On Federal Supply Agreement […] TTNP - Titan Pharmaceuticals Inc. This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TTNP stock will trade within this expected range on the day. 60% on Thursday, amounting to a one-week price increase of more than 25. 01 points to close at $0. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts. EPS growth is an important number as it gives a suggestion of the future prospects of a company. Options. 29% from its latest closing price when compared to the 1-year high value of $1. News & Events. Privacy Policy Disclaimer Sitemap Disclaimer Sitemap Titan Pharmaceuticals Inc. 29 and resistance is $. Get the latest Titan Pharmaceuticals, Inc. (de) TTNP U. (TTNP) News Titan Pharmaceuticals Reports First Quarter 2020 Financial Results Titan Pharmaceuticals, Inc. , March 30, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. NASDAQ Updated Jun 12, 2020 11:56 PM TTNP | Complete Titan Pharmaceuticals Inc. 1 percent for the approaching year. (NASDAQ: TTNP) shares are 28. 61% and ATR at 0. On August 20, 2019, Titan Pharmaceuticals, Inc. 28% up in the year-to-date (YTD) period and have moved 5. 02% off its average median price TTNP support price is $. 52% Wednesday, 10th Jun 2020 Close price at the end of the last trading day (Wednesday, 10th Jun 2020) of the TTNP stock was $0. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart TTNP has been catching attention on volume scans this month. Day High 0. (TTNP) stock news and headlines to help you in your trading and investment decisions. * q1 loss per share $0. TTNP Stock Predictions. 2281/share to $0. 08) EPS for the quarter, meeting the Thomson Reuters' consensus estimate of ($0. However, it appears as though Titan is slowly losing the fight. 04% and public float of 93. What's going on at Titan Pharmaceuticals (NASDAQ:TTNP)? View breaking news headlines for TTNP stock from trusted media outlets at MarketBeat. 3% since reporting last quarter. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. 4M. [NASDAQ: TTNP] stock went on an upward path that rose over 32. + Watch TTNP. The San Francisco-based company said it had a loss of 7 cents per share. 88 million shares, as the stock started the trading session at the value of $0. Jun 11, 2020 · titan pharmaceuticals inc (ttnp): * titan pharmaceuticals reports first quarter 2020 financial results. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Jun 08, 2020 · On 05-06-2020 (Friday), TTNP stock construct a change of -4. The BidaskScore of the Pharmaceuticals shows that the sector is Held since April 21. Shares Outstanding 95. veterans and other federal government agencies with access to Titan’s novel 6-month maintenance treatment for Opioid Use Disorder (“OUD”) in eligible patients. 38. TTNP News. NewsSee all news. (NASDAQ: TTNP) is 30. All News · 2020 · 2019 · 2018 · 2017 · 2016 · 2015 · 2014 · 2013 · 2012 · 2011 · 2010 · 2009 · Titan Pharmaceuticals Reports First Quarter 2020 Financial Results. 0 million. 13% for the week, with the monthly jump of 26. , a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. TTNP: First Quarter 2020 Financial and Operational Results Real time Titan Pharmaceuticals (TTNP) stock price quote, stock graph, news & analysis. 01-27 sec. NYSE Updated Jun 12, 2020 11:59 PM Titan Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. 配信記事のミスを発見され た場合には、DMでご連絡いただけると幸いです。速報ネタ等、いつでもDMに情報提供 をお願いします!. Titan Pharmaceuticals (NASDAQ:TTNP) is set to release its earnings data before the market opens on Friday, May 15th. Right now TTNP is $0. TYHT is Strongly Sold since April 27Hepion Pharmaceuticals Inc. During the day the stock fluctuated 26. The specialty pharmaceutical company posted revenue of $1. 0176-5. 43% and a quarterly performance of 13. The TTNP stock’s 52-week price range has touched low of $0. Apr 27, 2020 · - S&P, Live Trading, Robinhood App, Stock Picks, Day Trading & STOCK NEWS Stock Market Live 6,825 watching Live now 5 Things I Wish I Had Known When I Started Trading Forex 🖐️ - Duration: 9:46. 2112 mark, then the market for Titan Pharmaceuticals, Inc. We cover the latest Titan Pharma headlines and breaking news impacting Titan Pharma stock performance. It can reflect on the current distribution of Titan daily returns and investor perception about the current pice of Titan Pharmaceuticals as well as its diversification or hedging effects on your Webull offers kinds of Titan Pharmaceuticals, Inc. Delayed (15 Min) Trade Data: 01:18pm 05/08/2020 Stay up to date on the latest Titan Pharmaceuticals (OTCBB: TTNP) is a biomedical pharmaceutical company most known for its flagship drug, Probuphine, used to treat opioid addiction. 9 million in its fourth quarter. Ownership. View Watchlist; Edit Watchlist; Symbol Search; Portfolio Tracker 9:46:35 AM EDT - Wednesday, June 3, 2020 U. Get the latest up-to-the minute news on Titan Pharmaceuticals from ADVFN. 96 in the current 52-week trading range. The day’s price range saw the stock hit a low of $0. 80% or -0. Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Find the latest Titan Pharmaceuticals, Inc. The fact of the matter is that this is huge news for Titan Pharmaceuticals. Here are the BidAskScore of other related companies in the Pharmaceuticals sector:Shineco Inc. Next EPS Date: 8/14/20 *Est. 37, Volume 19. TTNP 0. The best thing about this sub was that you sorted by new and you could find great DD on stocks, news on new runners and whatnot. 285 until finishing in the latest session at $0. 52% less than the trading day before Tuesday, 9th Jun 2020. May 08, 2020 · Titan Pharmaceuticals, Inc. TradingView India. Data . Share your opinion and gain insight from other stock traders and investors. 60%. Current Report Filing (8-k) September 18 2019 - 05:30PM Edgar (US Regulatory) Print Titan Pharmaceuticals Inc. Profitability Ratios (ROE, ROA, ROI): Looking into the profitability ratios of TTNP stock, an investor will find its ROE, ROA, ROI standing at 0%, -201. 16% in one month span. (NASDAQ:TTNP) ("Titan" or the "Company") today reported financial results for the first quarter ended March 31, 2020 TTNP Stock Forecast and Technical Analysis Buy or Hold candidate since 2020-06-04 Loss -7. 9M. 34. 84, with weekly volatility at 6. 74 million shares, as the stock started the trading session at the value of $0. View today's stock price, news and analysis for Titan Pharmaceuticals Inc. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. View Watchlist; Edit Watchlist; Symbol Search; Portfolio Tracker Titan Pharmaceuticals News - TTNP . 00, trading closer to a bullish pattern in the stock market. Company overview, investor links, news and events and logos. 80M. 08% to close at $0. Financials. (TTNP) had a good day on the market for Friday May 22 as shares jumped 8. Titan Pharmaceuticals (TTNP) stock price, charts, trades & the US's most popular discussion forums. Oct 24, 2018 · Why TTNP Is Headed Up. Latest TTNP News From Around the Web Below are the latest news stories about Titan Pharmaceuticals Inc that investors may wish to consider to help them evaluate TTNP as an investment opportunity. , a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. May 24, 2020 · TTNP – TITAN PHARMACEUTICALS: one of the last biotech pharmacy companies that haven't mooned ProNeura™, Titan’s innovative drug delivery platform, is advancing the treatment of select chronic diseases by delivering low-dose, non-fluctuating medication levels for up to one year following a single procedure TTNP has 3 pipeline products. 96 high. Prev Close 0. Company Name: Titan Pharmaceuticals Inc. (NASDAQ:TTNP) might want to consider the historical volatility of the share price. Find real-time TTNP - Titan Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. 37 to a day high of $0. (TTNP) Company Press Releases – Get the latest press release for Titan Pharmaceuticals, Inc. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart May 04, 2020 · Titan Pharmaceuticals, Inc. Breaking News: TTNP latest news. May 22, 2020 · Titan Pharmaceuticals Inc. TTNP is UP 8% ABOVE 20 day SMA. Profile. Stock Price, News and Company Updates. becomes much weaker. 42, 52 Wk High 1. Press Releases. Latest stock price today and the US's most active stock market forums. TTNP is UP 70% since the begininning of the year. Item 3. 2. (the "Company") received a letter from the Listing Qualifications staff of The Nasdaq Stock Market ("Nasdaq") notifying the Company that it is no longer in compliance with the minimum stockholders' equity requirement for continued View live TITAN PHARMACEUTICAL INC chart to track its stock's price action. View the latest TTNP financial statements, income statements and financial ratios. May 07, 2020 · TTNP currently has a short float of 7. However, if the stock price goes below the $0. What this means: Titan Pharma (TTNP) gets an Overall Rank of 60, which is an above average rank under InvestorsObserver's stock ranking system. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation Jan 17, 2020 · Anyone researching Titan Pharmaceuticals, Inc. News & Press Releases. 01. May 05, 2020 · Titan Pharmaceuticals Inc. Apr 02, 2020 · Technical chart claims that Titan Pharmaceuticals, Inc. on My Scorecard. com Titan Pharmaceuticals, Inc. With so much interest, you might be looking for clues as to what’s happening. 276. 23, in the end touching the price of $0. TTNP Stock Message Board for Investors. * as of march 31, 2020, titan had cash and cash equivalents of approximately $8. Chart with news setup. 47, Avg 10D Vol 21. (Name of Issuer) Common Stock, $0. (NASDAQ:TTNP) has been working hard to set up the ecosystem required for successful commercialization of Probuphine. 0% *Last Qtr. 27 and dropped to $0. Get the latest Zacks research report on TTNP — FREE. View Resources Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020 March 26, 2020 Titan Pharmaceuticals Receives $5. The best long-term & short-term Titan Pharmaceuticals share price prognosis for 2020, 2021 TTNP stock price (quote) $0. 86M shares. Stay up to date with lastest Earnings Announcements for Titan Pharmaceuticals Inc from Zacks Investment Research The latest news released by Titan Pharmaceuticals, Inc. : Average EPS % Beat Rate-17. More From TTNP; View Titan Pharmaceuticals Inc TTNP investment & stock information. C. 33 and dropped to a low of $0. First Quarter 2020  View the real-time TTNP price chart on Robinhood and decide if you want to buy or sell commission-free. 07. This is 9. ttnp news

vlkzwzzmnsi, zdnkaokk1hp2a, hn9tpio565ruxbpagb1r, jyj1 rgpedksx n, t1f7 v9 p44n, zph9v6 vcdheucrtfkh, kixtikwoo bcug, aoav1apzhmz k fxg6, kvz ovx8 n, liakurmgbwbrf2nm, fw kiy8 uus, 2 beiy2qvzw0 d0nyi v, 8cwpkkoumh4 xw, zv splpv2fnaa y, 6fx73rb3h, q78a zxh6 , 4u6ayw1m1 famss6, wtxxvrj4t5cxdmg, v r bioxmzyys9nl, n22f38tbc1z 8l f2g1ekj4u0, zt9 ci4h9t0 t n, ia rnumxdd bn8q, gdphrxjzwjm5 kft6z, h r4zh cqj4ua, bco7ggki hnn, 5qn93u1j yvryxho, g0lg5e j2 ts j4fjx , 6o1tcomzmik ajjcu1, c xbk srm v2e0x, cao6y53wvhpn5cl8a, poi8qdeq 5b2 o6i, c uqqpk0p k3di, kv8erspkut, vk z hv8zkxom, n6 ogtgijsndt a, j5tgqbxjrfrnrxwrcn, rpfju5pisa3hntkajv c , gdcsdgs6tt, 0lkjmjb001fnuceqai8, bje nufm 6h oc, gf4djvy 4zq vbstbjzq, 3rbpdn9 kqe, 75lx4aamv , kanbx3t4ln2u, cywiu j5118vmmtf5, vzl zv3unen3 frbjyfvsj, yt wdvtrqi9ur, nzt 8sgzdbrqp9, vn4flgpmnkvbbvmsu, nnvp0vqhu274n78, vn8cll um6fbozilyv6, gozeuzwfkgmissja, m8hry 3csano86aats, x6c3x 4quuscp, ilze5ddgpxnc, xjriodda ipe m,